Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathy
Open Access
- 15 August 1999
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 104 (4), 469-481
- https://doi.org/10.1172/jci6067
Abstract
Multiple mutations in cardiac troponin T (cTnT) can cause familial hypertrophic cardiomyopathy (FHC). Patients with cTnT mutations generally exhibit mild or no ventricular hypertrophy, yet demonstrate a high frequency of early sudden death. To understand the functional basis of these phenotypes, we created transgenic mouse lines expressing 30%, 67%, and 92% of their total cTnT as a missense (R92Q) allele analogous to one found in FHC. Similar to a mouse FHC model expressing a truncated cTnT protein, the left ventricles of all R92Q lines are smaller than those of wild-type. In striking contrast to truncation mice, however, the R92Q hearts demonstrate significant induction of atrial natriuretic factor and β-myosin heavy chain transcripts, interstitial fibrosis, and mitochondrial pathology. Isolated cardiac myocytes from R92Q mice have increased basal sarcomeric activation, impaired relaxation, and shorter sarcomere lengths. Isolated working heart data are consistent, showing hypercontractility and diastolic dysfunction, both of which are common findings in patients with FHC. These mice represent the first disease model to exhibit hypercontractility, as well as a unique model system for exploring the cellular pathogenesis of FHC. The distinct phenotypes of mice with different TnT alleles suggest that the clinical heterogeneity of FHC is at least partially due to allele-specific mechanisms. J. Clin. Invest.104:469-481 (1999).Keywords
This publication has 49 references indexed in Scilit:
- Dominant-negative effect of a mutant cardiac troponin T on cardiac structure and function in transgenic mice.JCI Insight, 1998
- A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy.JCI Insight, 1998
- Diastolic dysfunction and altered energetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy.JCI Insight, 1998
- Expression and functional assessment of a truncated cardiac troponin T that causes hypertrophic cardiomyopathy. Evidence for a dominant negative action.JCI Insight, 1996
- Thin Filament-Mediated Regulation of Cardiac ContractionAnnual Review of Physiology, 1996
- Altered cardiac troponin T in vitro function in the presence of a mutation implicated in familial hypertrophic cardiomyopathy.JCI Insight, 1996
- Ischemic myocardial mitochondrial function and ultrastructural change. Influence of regional myocardial blood flow.Japanese Circulation Journal, 1991
- Southwestern Internal Medicine Conference: Hypertrophic Cardiomyopathy: Current Views on Etiology, Pathophysiology, and ManagementThe American Journal of the Medical Sciences, 1987
- Hypertrophic CardiomyopathyNew England Journal of Medicine, 1987
- Electron microscopic investigation of endomyocardial biopsy samples in hypertrophy and cardiomyopathy. A semiquantitative study in 48 patients.Circulation, 1981